BioToxTech, 25.1% Increase Amid Rising Trend in COVID-19 (Diagnostic Kit) Theme

On the 19th, the COVID-19 (diagnostic kit) theme showed strength by rising 3.01% compared to the previous day, while BioToxTech, a related stock attracting attention, surged 25.1% compared to the previous day. BioToxTech is known as a leading domestic CRO company specializing in non-clinical trials.

[Graph] Major stock price changes in the COVID-19 (diagnostic kit) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, BioToxTech's quant financial score is 20.56 points, showing higher stability and profitability scores than the average of other stocks related to COVID-19 (diagnostic kits), but its quant financial ranking was only 18th out of 35 stocks. On the other hand, Huons ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.